by Lane Simonian | May 06, 2023 1:58 AM ET
![](https://alzheon.com/wp-content/uploads/2023/05/seekingalpha_image_92003014.webp)
NickS/E+ via Getty Images
- Alzheon’s ALZ-801 is as effective as other anti-amyloid drugs such as Aduhelm, Leqembi, and donanemab but without brain bleeds and brain swelling due to a different mechanism of action.
- A number of factors could in the long run negatively affect each company’s stock prices, including additional deaths and the potential approval of ALZ-801 in a couple of years.